Mark Kevin Hunter
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Mark Kevin Hunter
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Miscellaneous Commercial Services | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark Kevin Hunter
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| RXELITE, INC. | Pharmaceuticals: Major | Corporate Secretary | |
| MARATHON DIGITAL HOLDINGS, INC. | Data Processing Services | President | |
| NEXTPLAT CORP | Precious Metals | Chief Executive Officer | |
| Calima Group LLC | President | ||
| CUE BIOPHARMA, INC. | Biotechnology | Chief Executive Officer | |
| George Washington University Law School | College/University | Graduate Degree | |
| University of Virginia | College/University | Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
ICAP Patent Brokerage LLC
 ICAP Patent Brokerage LLC Real Estate DevelopmentFinance ICAP Patent Brokerage LLC provides intellectual property brokerage, live patent auction, and sealed-bid patent auction services. It operates a live auctioning platform for the buyers and sellers of patents and other intellectual property assets. The company is headquartered in New York, NY. | Real Estate Development | Corporate Officer/Principal | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Investment Banks/Brokers | Corporate Officer/Principal | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member | |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Biotechnology | Founder | |
| Alcedo Capital, Inc. | Founder |
Statistik
International
| Vereinigte Staaten | 16 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 11 |
| Corporate Secretary | 6 |
| Treasurer | 5 |
| President | 4 |
| Director of Finance/CFO | 4 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Cameron Gray | 11 |
| Andrew Uribe | 6 |
| Nikolay Koval | 1 |
| Ravilya Islyntieva | 1 |
| Olga Shenberger | 1 |
| Roman Urkevitch | 1 |
- Börse
- Insiders
- Mark Kevin Hunter
- Unternehmensverbindungen
